Get the Stockscreener App
430.32
3.19%
13.30
After Hours:
430.32
Medpace Holdings Inc stock is traded at $430.32, with a volume of 421.41K.
It is up +3.19% in the last 24 hours and down -13.65% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$417.02
Open:
$419
24h Volume:
421.41K
Relative Volume:
1.00
Market Cap:
$12.29B
Revenue:
$2.68B
Net Income/Loss:
$460.40M
P/E Ratio:
27.07
EPS:
15.8963
Net Cash Flow:
$711.00M
1W Performance:
+5.05%
1M Performance:
-13.65%
6M Performance:
-28.14%
1Y Performance:
+43.21%
1-Day Range:
$413.35
$433.96
1-Week Range:
$402.44
$433.96
52-Week Range:
$284.10
$628.92
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
430.32 | 11.91B | 2.68B | 460.40M | 711.00M | 15.90 |
TMO
Thermo Fisher Scientific Inc
|
466.76 | 171.91B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.63 | 123.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.97 | 44.73B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
342.75 | 29.63B | 3.17B | 642.63M | 516.49M | 10.77 |
A
Agilent Technologies Inc
|
117.53 | 31.70B | 7.07B | 1.29B | 993.00M | 4.5355 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-18-26 | Upgrade | TD Cowen | Sell → Hold |
| Feb-13-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-10-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, - GlobeNewswire
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - ChartMill
MEDP Shareholder Alert: Medpace Holdings, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - PR Newswire
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
MEDP Legal Alert: Medpace Hit with Securities Fraud Class Action Over Cancellation Rates and Corresponding 16% Stock Drop - PR Newswire
Medpace Holdings: 26.5% Revenue Growth Masks A 0.88 Book-To-Bill Warning Signal! - Smartkarma
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th - GlobeNewswire Inc.
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMEDP - TMX Newsfile
Lawsuit filed for Investors in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) in effort to recover Losses - openPR.com
Jefferies upgrades Medpace Holdings (MEDP) - MSN
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to ... - Caledonian Record
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Medpace Holdings Shows Strong Growth Amid Biotech Funding Cycles - HarianBasis.co
Is Medpace Holdings, Inc. (MEDP) A Good Stock To Buy Now? - Insider Monkey
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-05-03 | MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! | NDAQ:MEDP | Press Release - Stockhouse
$MEDP Class Action Lawsuit: Did Medpace Mislead Investors About Its Cancellation Rates? Securities Class Action is Pending - ACCESS Newswire
MEDP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - marketscreener.com
Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Medpace sees $1.94B backlog conversion over next 12 months as cancellations rise - MSN
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
MEDP Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
Vanguard Group Inc. Lowers Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Oppenheimer Asset Management Inc. Decreases Holdings in Medpace Holdings, Inc. $MEDP - MarketBeat
Consolidated Press International Holdings Ltd's Medpace Holdings Inc(MEDP) Holding History - GuruFocus
Investor Notice: Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action - lincolnjournal.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMEDP - ChartMill
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Laws - GuruFocus
Medpace Holdings Secures Strong Position in Bares Capital Portfolio - HarianBasis.co
Medpace Holdings Inc. (MEDP): Bares Capital Trims Stake - Insider Monkey
MEDP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - Morningstar
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Cancellation Rate Risks: SueWallSt - Barchart.com
2026-04-30 | MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:MEDP | Press Release - Stockhouse
UBS Group AG Acquires 81,250 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Robbins LLP Reminds MEDP Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Medpace Holdings Inc. - ChartMill
ROSEN, A LEADING LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMEDP - TMX Newsfile
Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders - GlobeNewswire
$MEDP Fraud: Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law - GlobeNewswire
Medpace Faces Class Action Lawsuit for Securities Fraud - Intellectia AI
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Medpace ($MEDP) Investors Are Notified That The Company Was Sued For Securities FraudJune 8 Deadline Approaching - ACCESS Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMEDP - TMX Newsfile
Medpace (NASDAQ: MEDP) CEO awarded 10,000 RSUs and 20,000 stock options - Stock Titan
Medpace (NASDAQ: MEDP) GC exercises options and receives major equity grants - Stock Titan
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):